✦ LIBER ✦

The JAK2 V617F mutation occurs frequently in myelodysplastic/myeloproliferative diseases, but is absent in true myelodysplastic syndromes with fibrosis

✍ Scribed by Kremer, M; Horn, T; Dechow, T; Tzankov, A; Quintanilla-Martínez, L; Fend, F

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reply to Kremer M et al., The JAK2 V617F

✍ Ohyashiki, K; Ohyashiki, J H 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 67 KB

Different lineage involvement in myelody

✍ Kais Hussein; Katharina Theophile; Thomas Buhr; Alexandra Beller; Hans Kreipe; O 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB

The JAK2 V617F tyrosine kinase mutation

✍ Ohyashiki, K; Aota, Y; Akahane, D; Gotoh, A; Miyazawa, K; Kimura, Y; Ohyashiki, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 109 KB

Prognostic interaction between thrombocy

✍ Atallah, E; Nussenzveig, R; Yin, C C; Bueso-Ramos, C; Tam, C; Manshouri, T; Pier 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 111 KB